123 related articles for article (PubMed ID: 7461266)
21. The involvement of prostaglandin endoperoxide formation in the elevation of cyclic GMP levels during platelet aggregation.
Glass DB; Gerrard JM; Townsend D; Carr DW; White JG; Goldberg ND
J Cyclic Nucleotide Res; 1977 Feb; 3(1):37-44. PubMed ID: 191476
[TBL] [Abstract][Full Text] [Related]
22. The effect of sulphinpyrazone and other drugs on the platelet response during the acute phase of the active Arthus reaction in guinea pigs.
Butler KD; Pay GF; Roberts JM; White AM
Thromb Res; 1979; 15(3-4):319-40. PubMed ID: 158844
[No Abstract] [Full Text] [Related]
23. Platelets and prostaglandins in coronary artery disease. Rationale for use of platelet-suppressive drugs.
Mehta J
JAMA; 1983 May; 249(20):2818-23. PubMed ID: 6341645
[No Abstract] [Full Text] [Related]
24. Antiplatelet agents: rationale and results.
Kelton JG
Clin Haematol; 1983 Feb; 12(1):311-54. PubMed ID: 6132693
[No Abstract] [Full Text] [Related]
25. Long-lasting inhibition of platelet prostaglandin but normal vascular prostacyclin generation following sulphinpyrazone administration to rats.
Livio M; Villa S; de Gaetano G
J Pharm Pharmacol; 1980 Oct; 32(10):718-9. PubMed ID: 6107351
[No Abstract] [Full Text] [Related]
26. Sulphinpyrazone prevents in vivo the inhibitory effect of aspirin on rat platelet cyclo-oxygenase activity.
Rajtar G; Cerletti C; Livio M; de Gaetano G
Biochem Pharmacol; 1981 Oct; 30(20):2773-6. PubMed ID: 6797431
[No Abstract] [Full Text] [Related]
27. On the formation and effects of thromboxane A2 in human platelets.
Svensson J; Hamberg M; Samuelsson B
Acta Physiol Scand; 1976 Nov; 98(3):285-94. PubMed ID: 998278
[TBL] [Abstract][Full Text] [Related]
28. Effects of aspirin and sulfinpyrazone on platelet prostaglandin synthesis.
McDonald JW; Stuart RK; Barnett HJ
Adv Exp Med Biol; 1977; 82():222-4. PubMed ID: 920363
[No Abstract] [Full Text] [Related]
29. Platelet prostaglandins and related compounds in diabetes mellitus.
Lagarde M; Berciaud P; Burtin M; Soulier M; Velardo B; Dechavanne M
Adv Exp Med Biol; 1984; 164():119-25. PubMed ID: 6421100
[No Abstract] [Full Text] [Related]
30. The role of prostaglandin endoperoxides and thromboxanes in platelet aggregation.
Samuelsson B; Hamberg M; Malmsten C; Svensson J
Adv Prostaglandin Thromboxane Res; 1976; 2():737-46. PubMed ID: 983874
[No Abstract] [Full Text] [Related]
31. In vitro evaluation of inhibitors of platelet release and aggregation.
Rosenberg JC; Sell TL
Arch Surg; 1975 Aug; 110(8):980-3. PubMed ID: 168838
[TBL] [Abstract][Full Text] [Related]
32. Cyclic AMP inhibits synthesis of prostaglandin endoperoxide (PGG2) in human platelets.
Malmsten C; Granström E; Samuelsson B
Biochem Biophys Res Commun; 1976 Jan; 68(2):569-76. PubMed ID: 175797
[No Abstract] [Full Text] [Related]
33. Prostaglandins and platelets.
Mustard JF; Kinlough-Rathbone RL; Packham MA
Annu Rev Med; 1980; 31():89-96. PubMed ID: 6994628
[TBL] [Abstract][Full Text] [Related]
34. Prostaglandin receptors on human platelets. Structure-activity relationships of stimulatory prostaglandins.
MacIntyre DE; Salzman EW; Gordon JL
Biochem J; 1978 Sep; 174(3):921-9. PubMed ID: 215124
[TBL] [Abstract][Full Text] [Related]
35. Sulphinpyrazone metabolism during long-term therapy.
Pedersen AK; Jakobsen P
Br J Clin Pharmacol; 1981 Jun; 11(6):597-603. PubMed ID: 7272176
[TBL] [Abstract][Full Text] [Related]
36. Coffee extracts inhibit platelet aggregation in vivo and in vitro.
Bydlowski SP; Yunker RL; Rymaszewski Z; Subbiah MT
Int J Vitam Nutr Res; 1987; 57(2):217-23. PubMed ID: 3115908
[TBL] [Abstract][Full Text] [Related]
37. A serial study of platelet reactivity throughout the first six months after myocardial infarction: its modification by sulphinpyrazone.
Kubik MM; Richardson SG
Postgrad Med J; 1987 May; 63(739):351-6. PubMed ID: 3118351
[TBL] [Abstract][Full Text] [Related]
38. Effects of adenosine 3':5'-monophosphate and platelet aggregation on thromboxane biosynthesis in human platelets.
Lindgren JA; Claesson HE; Kindahl H; Hammarström S
FEBS Lett; 1979 Feb; 98(2):247-50. PubMed ID: 217731
[No Abstract] [Full Text] [Related]
39. Prostaglandin endoperoxides and thromboxane A2 can induce platelet aggregation in the absence of secretion.
Charo IF; Feinman RD; Detwiler TC; Smith JB; Ingerman CM; Silver MJ
Nature; 1977 Sep; 269(5623):66-9. PubMed ID: 895887
[No Abstract] [Full Text] [Related]
40. Increased synthesis of prostaglandin-E-like material by platelets from patients with diabetes mellitus.
Halushka PV; Lurie D; Colwell JA
N Engl J Med; 1977 Dec; 297(24):1306-10. PubMed ID: 917087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
